Azelaic acid gel 15%: Clinical versatility in the treatment of rosacea

被引:0
|
作者
Del Rosso, James Q. [1 ]
Baum, Eric W.
Draelos, Zoe Diana
Elewski, Boni E.
Fleischer, Alan B., Jr.
Kakita, Lenore S.
Thiboutot, Diane
机构
[1] Univ Nevada, Sch Med, Dept Dermatol, Las Vegas, NV 89154 USA
[2] Touro Univ, Nevada Coll Osteopath Med, Henderson, NV USA
[3] Wake Forest Univ, Sch Med, Dept Dermatol, Winston Salem, NC 27109 USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[6] Penn State Univ, Coll Med, Hershey, PA USA
来源
CUTIS | 2006年 / 78卷 / 05期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
There are numerous proposed but contested components involved in the pathophysiology of rosacea, including inflammatory mediators, reactive oxygen species (ROS) released by neutrophils, and microbial components. Ideal comprehensive rosacea management should address these components. Azelaic acid (AzA), a naturally occurring substance, has many proposed mechanisms of action-antimicrobial, anti-inflammatory/antioxidant, and keratinolytic-that address the proposed components of rosacea pathophysiology and has demonstrated efficacy in subtype 2 rosacea. In a roundtable discussion, information leaders discussed the pathophysiology of rosacea and other issues of importance to successful rosacea management, such as skin care regimens, quality of life (OOL), and compliance.
引用
收藏
页码:6 / 19
页数:14
相关论文
共 50 条